Cargando…
Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
In the midst of the ongoing COVID-19 coronavirus pandemic, influenza virus remains a major threat to public health due to its potential to cause epidemics and pandemics with significant human mortality. Cases of H7N9 human infections emerged in eastern China in 2013 and immediately raised pandemic c...
Autores principales: | Pushko, Peter, Tretyakova, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291233/ https://www.ncbi.nlm.nih.gov/pubmed/32397182 http://dx.doi.org/10.3390/v12050518 |
Ejemplares similares
-
Evaluation of Protective Efficacy of Influenza Virus Like Particles Prepared from H5N1 Virus of Clade 2.2.1.2 in Chickens
por: El-Husseiny, Mohamed H., et al.
Publicado: (2021) -
Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
por: Kang, Hae-Ji, et al.
Publicado: (2019) -
114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014) -
Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023) -
Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins
por: Wang, Min, et al.
Publicado: (2017)